<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02050464</url>
  </required_header>
  <id_info>
    <org_study_id>207094</org_study_id>
    <nct_id>NCT02050464</nct_id>
  </id_info>
  <brief_title>Computational Tools for Early Diagnosis of Memory Disorders</brief_title>
  <acronym>ProsKuopio</acronym>
  <official_title>Virtual Physiological Human (VPH) Dementia Research Enabled by IT - Prospective Cohort Kuopio</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Eastern Finland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Sheffield</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VTT Technical Research Centre of Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinik Hirslanden, Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sheffield Teaching Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Eastern Finland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Virtual Physiological Human: DementiA Research Enabled by IT (VPH-DARE@IT) is a four-year
      IT-project funded through the European Union (EU). The project consortium involves a total of
      21 universities and industrial partners from 10 European countries. The project delivers the
      first patient-specific predictive models for early differential diagnosis of dementia and
      their evolution. An integrated clinical decision support platform will be validated / tested
      by access to a dozen databases of international cross-sectional and longitudinal studies. As
      a part of the VPH-DARE@IT project, a new prospective cohort will be collected in Kuopio. This
      prospective cohort will be used to test further the modeling approaches and tools developed
      by using the retrospective databases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Virtual Physiological Human: DementiA Research Enabled by IT (VPH-DARE@IT) is a four-year
      IT-project funded through the European Union (EU). The project will develop multiscale models
      of the ageing brain in order to account simultaneously for the patient-specific biochemical,
      metabolic and biomechanical brain substrate, as well as for genetic, clinical, demographic
      and lifestyle determinants. An integrated clinical decision support platform will be
      validated and tested by access to a dozen databases of international cross-sectional and
      longitudinal studies.

      Modeling approaches developed by using the retrospective databases will be tested using a new
      prospective cohort that will be collected in Kuopio as a part of the VPH-DARE@IT project. The
      study population at university of Eastern Finland (UEF) will be a total of 120 subjects: 20
      healthy controls (HC), 20 mild to moderate Alzheimer's disease (AD) patients, 20 vascular
      dementia (VAD) patients, 20 fronto-temporal dementia (FTD) patients and 40 subjects with mild
      cognitive impairment (MCI). This study is referred as VPH-DARE@IT Prospective study in Kuopio
      or &quot;ProsKuopio&quot;.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>18 Months</target_duration>
  <primary_outcome>
    <measure>Sensitivity, specificity and accuracy of models for diagnosis of memory disorders</measure>
    <time_frame>during a single visit, i.e., day 1 and for one study group (MCI) after 18 month follow-up</time_frame>
    <description>The models developed the VPH-DARE project will be tested in this prospective cohort. Sensitivity, specificity and accuracy of the model will be tested in differential diagnosis between the study groups as well as the accuracy of prediction cognitive decline as measured by neuropsychological test battery in the MCI group.</description>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Actual">126</enrollment>
  <condition>Alzheimer Disease</condition>
  <condition>Frontotemporal Dementia</condition>
  <condition>Dementia, Vascular</condition>
  <condition>Mild Cognitive Impairment</condition>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>Healthy controls</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Alzheimer's disease</arm_group_label>
    <description>Patients with mild Alzheimer's disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vascular dementia</arm_group_label>
    <description>Patients with vascular dementia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fronto-temporal dementia</arm_group_label>
    <description>Patients with fronto-temporal dementia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mild cognitive impairment</arm_group_label>
    <description>Patients with mild cognitive impairment</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum, plasma, white cells
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Control subjects with normal cognition

        The Alzheimer's disease, Fronto-temporal dementia, Vascular dementia, and Mild Cognitive
        Impairment will be recruited during their visit in the Neurological clinic at the Kuopio
        University Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Inclusion criteria for subjects with dementia (AD, VAD, FTD) - The inclusion criteria will
        be based on international research criteria:

          -  Diagnosis of probable AD according to National Institute of Neurological and
             Communicative Disorders and Stroke Alzheimer's (NINCDS-ADRDA) criteria (McKhann et
             al.1984) and diagnosis of prodromal AD according to Dubois et al., 2007 criteria

          -  Diagnosis of FTD according to the clinical diagnostic criteria of Neary et al., 1998

          -  Diagnosis of VAD according to diagnostic criteria for research studies by the
             NINDSAIREN International Workshop (Rom√°n et al., 1993)

        Inclusion criteria for subjects with MCI

          -  Referral because of cognitive impairments

          -  Diagnosis criteria for amnestic and nonamnestic MCI (Petersen, 2004, Petersen and
             Morris, 2005)

        Inclusion criteria for control subjects

          -  Mini-mental state examination (MMSE) score above or equal to 27

          -  Overall score on the Clinical Dementia Rating (CDR) scale of 0

        Exclusion Criteria:

        Exclusion criteria for all subjects

          -  Other causes of dementia

          -  Obvious brain, systemic or psychiatric disorders that could potentially affect
             cognitive functions such as stroke, severe depression, or endocrine disorders

        Exclusion criteria for control subjects and subjects with MCI

        - Diagnosis of dementia according to DSM-IV (Diagnostic and Statistical Manual of Mental
        Disorders, 4th Edition) criteria at baseline
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hilkka Soininen, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Eastern Finland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurology and Brain Research Unit, Institute of Clinical Medicine, University of Eastern Finland</name>
      <address>
        <city>Kuopio</city>
        <zip>FI-70211</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <zip>FI-70211</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VTT Technical Research Centre of Finland</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <link>
    <url>http://www.vph-dare.eu</url>
    <description>Click here for more information about VPH-DARE@IT project</description>
  </link>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2014</study_first_submitted>
  <study_first_submitted_qc>January 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2014</study_first_posted>
  <last_update_submitted>May 3, 2017</last_update_submitted>
  <last_update_submitted_qc>May 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Eastern Finland</investigator_affiliation>
    <investigator_full_name>Hilkka Soininen</investigator_full_name>
    <investigator_title>Hilkka Soininen, Professor, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Alzheimer Disease</keyword>
  <keyword>Frontotemporal Dementia</keyword>
  <keyword>Dementia, Vascular</keyword>
  <keyword>Mild Cognitive Impairment</keyword>
  <keyword>Diagnosis</keyword>
  <keyword>Risk factors</keyword>
  <keyword>Biomarkers</keyword>
  <keyword>AD</keyword>
  <keyword>FTD</keyword>
  <keyword>VAD</keyword>
  <keyword>MCI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Frontotemporal Dementia</mesh_term>
    <mesh_term>Aphasia, Primary Progressive</mesh_term>
    <mesh_term>Pick Disease of the Brain</mesh_term>
    <mesh_term>Dementia, Vascular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

